Regional fibroblast heterogeneity in the lung: implications for remodeling.
about
The extracellular matrix - the under-recognized element in lung disease?Regional heterogeneity in murine lung fibroblasts from normal mice or mice exposed once to cigarette smokeSevere asthma: lessons learned from the National Heart, Lung, and Blood Institute Severe Asthma Research Program.Altered fibroblast proteoglycan production in COPD.Activation of WNT/β-catenin signaling in pulmonary fibroblasts by TGF-β₁ is increased in chronic obstructive pulmonary disease.Enhanced ROCK1 dependent contractility in fibroblast from chronic obstructive pulmonary disease patients.IL-4 induces differentiation of human embryonic stem cells into fibrogenic fibroblast-like cells.The effect of cathepsin K deficiency on airway development and TGF-β1 degradation.The K+ channel KCa3.1 as a novel target for idiopathic pulmonary fibrosisHuman lung myofibroblast TGFβ1-dependent Smad2/3 signalling is Ca(2+)-dependent and regulated by KCa3.1 K(+) channelsInterleukin-1beta induces increased transcriptional activation of the transforming growth factor-beta-activating integrin subunit beta8 through altering chromatin architectureMatrix, mesenchyme, and mechanotransductionGenomic differences distinguish the myofibroblast phenotype of distal lung fibroblasts from airway fibroblasts.Lipoxin A4 Attenuates Constitutive and TGF-β1-Dependent Profibrotic Activity in Human Lung MyofibroblastsCultured lung fibroblasts from ovalbumin-challenged "asthmatic" mice differ functionally from normal.Epithelial-mesenchymal interactions in pulmonary fibrosis.The regulatory role of TGF-beta in airway remodeling in asthma.Update in asthma 2006.Lung fibroblast repair functions in patients with chronic obstructive pulmonary disease are altered by multiple mechanisms.Glycogen synthase kinase-3 (GSK-3) regulates TGF-β₁-induced differentiation of pulmonary fibroblasts.Immunologic and inflammatory mechanisms that drive asthma progression to remodelingMyofibroblast differentiation and survival in fibrotic disease.Fluticasone/salmeterol reduces remodelling and neutrophilic inflammation in severe equine asthma.MAPK regulation of IL-4/IL-13 receptors contributes to the synergistic increase in CCL11/eotaxin-1 in response to TGF-β1 and IL-13 in human airway fibroblastsChamber-specific differences in human cardiac fibroblast proliferation and responsiveness toward simvastatin.Differential effects of fluticasone on extracellular matrix production by airway and parenchymal fibroblasts in severe COPD.Human lung parenchyma but not proximal bronchi produces fibroblasts with enhanced TGF-beta signaling and alpha-SMA expression.Oncostatin M modulates fibroblast function via signal transducers and activators of transcription proteins-3.Targeting HIF-1α/PDK1 Axis by Dichloroacetate (DCA) Suppresses Bleomycin-induced Pulmonary Fibrosis.Severe bronchial asthma in children: a review of novel biomarkers used as predictors of the disease.Human bronchial and parenchymal fibroblasts display differences in basal inflammatory phenotype and response to IL-17A.Single-Cell Deconvolution of Fibroblast Heterogeneity in Mouse Pulmonary Fibrosis.Mesenchymal stem cell-conditioned media recovers lung fibroblasts from cigarette smoke-induced damage.Fibroblast-to-myofibroblast transition in bronchial asthma
P2860
Q28075842-D3FC08B3-7217-4852-B7DB-1CBE260C0289Q28727828-1FB4ABF3-2340-42D6-B634-83C8D8C0EAAFQ30422401-0557B61F-81B1-4613-BAB8-A6E74FB47576Q33575567-35F4BF7A-43C5-4FD0-A457-2DEEC8576D66Q34043208-B8D3A442-D5FC-4901-9EFE-B627675C61D6Q34389888-2BCF737A-3372-4E61-BF55-15EEEAD20806Q35017190-711D9D6C-C769-448B-9624-E4C31502CD07Q35073995-4E7B3992-A449-4D60-B471-BFAF47A6DF7DQ35083097-61484355-5D4F-4C29-B097-1C647EE38F21Q35232951-1AAC9F07-4E0F-47FD-8D0F-400629261B31Q35378909-C2779D49-AC20-4492-9112-A7748009AA4EQ35604443-8FA0E833-6D2E-432A-A57F-6BCEBC51B166Q35684810-A4C6DC00-452D-4698-8862-EAD5D48231F4Q36029120-50C90B2A-A41B-407A-9F0F-2A8477CA4FC7Q36330682-12708C3F-70C8-4CA0-BEA1-BADB149BAF07Q36427136-D8822629-E095-40FE-9348-004CEF2DDA8BQ36746333-4D3850DF-0F9F-405B-AAD0-146FDFC53A87Q36769699-6217B779-DA2A-458E-8E9E-133F35C9DB9EQ36889916-082692A7-A16D-4398-AD67-54C988949BEEQ36929443-2FDCB2C3-910F-4EB1-ACB2-99676FD2BF48Q37105324-47DF2CF4-4204-41E4-AC5C-E8B7270B317AQ37921386-1BB2DCAF-A207-4EB8-ADDA-1D90F715F2F4Q41460094-C5F519B9-E01C-4B49-B681-A8C6D036CA9AQ42187121-9A952BAF-C814-4859-A4C2-BA62DB4405DFQ42361266-DF358594-3735-4F8B-B9C2-60E2B8766CCDQ42444004-956BD96D-A8AA-4859-8551-27EC3EBC3C30Q42465609-B3B70E6D-80AA-47D8-ADAF-60CD0F669A23Q46716189-E9A1E1B4-5421-4DBD-933A-89B032F7D1F0Q46792366-626F7145-5050-4009-A9C4-1CC074117F88Q49201946-BFA65782-7B2B-46CF-9433-F703C49CAE26Q51532361-5B147C93-0689-463D-90A4-E93268775EAAQ52723535-DF06DACB-98EB-4245-B16D-E1CC20E76749Q53187588-072D914D-8D8A-4175-89AF-905147F5950BQ58787537-1E267F69-08EB-4852-88F5-08011F238C08
P2860
Regional fibroblast heterogeneity in the lung: implications for remodeling.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 March 2006
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Regional fibroblast heterogeneity in the lung: implications for remodeling.
@en
Regional fibroblast heterogeneity in the lung: implications for remodeling.
@nl
type
label
Regional fibroblast heterogeneity in the lung: implications for remodeling.
@en
Regional fibroblast heterogeneity in the lung: implications for remodeling.
@nl
prefLabel
Regional fibroblast heterogeneity in the lung: implications for remodeling.
@en
Regional fibroblast heterogeneity in the lung: implications for remodeling.
@nl
P2093
P2860
P1476
Regional fibroblast heterogeneity in the lung: implications for remodeling.
@en
P2093
Chakradhar Kotaru
Haizhen Hu
John B Trudeau
Kathryn J Schoonover
Mai-Lan Huynh
Sally E Wenzel
XiuXia Zhou
P2860
P304
P356
10.1164/RCCM.200508-1218OC
P407
P577
2006-03-16T00:00:00Z